Ho Hsiang Yeh
Directeur Général chez Rossmax Pharmaceutical Corp.
Provenance du réseau au premier degré de Ho Hsiang Yeh
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Rossmax Pharmaceutical Corp.
3
| Subsidiary | 3 | |
Cardiocare Co., Ltd.
3
| Subsidiary | 3 | |
Atlantean Corp.
 Atlantean Corp. Engineering & ConstructionIndustrial Services Atlantean Corp. engages in the engineering and product development of health care products. The frim offers plus oximeter and triggered nebulizer bottle set. The company was founded in 2008 and is headquartered in Hsinchu, Taiwan.
3
| Subsidiary | Engineering & Construction | 3 |
Rossmax Innotek Corp.
2
| Subsidiary | 2 | |
RMJ Corp. Ltd.
2
| Subsidiary | 2 | |
Rossmax (Shanghai) Incorporation Ltd.
 Rossmax (Shanghai) Incorporation Ltd. Medical SpecialtiesHealth Technology Part of Rossmax International Ltd., Rossmax (Shanghai) Incorporation Ltd. is a Chinese company that manufactures and distributes electrometrical devices. The company is based in Shanghai, China.
1
| Subsidiary | Medical Specialties | 1 |
Ho Sang Medical Technology Co., Ltd.
1
| Private Company | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ho Hsiang Yeh via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ROSSMAX INTERNATIONAL LTD. | Medical Distributors | Chief Executive Officer Chief Administrative Officer Director of Finance/CFO | |
| WE CAN MEDICINES CO., LTD. | Drugstore Chains | Director/Board Member Director/Board Member Director/Board Member | |
| National Chengchi University | College/University | Undergraduate Degree Undergraduate Degree | |
Tranquis Therapeutics, Inc.
 Tranquis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tranquis Therapeutics, Inc. discovers and develops novel immuno-therapeutics for neurological diseases. It offers treatment for central nervous system (CNS) disorders, including Amyotrophic Lateral Sclerosis, Parkinson 's disease, Alzheimer?s Disease, and age-related neuropathology. The company was founded by Chih-Ping Liu and Khoa D. Nguyen in June 2016 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Founder | |
Angarus Therapeutics, Inc.
 Angarus Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Angarus Therapeutics, Inc. engages in the development of immuno-oncology therapies. It specializes in modulating the tumor microenvironment by activating innate immunity. The company was founded by Ling Yin Li, Chih Ping Liu, and Mark Smith and is headquartered in Sunnyvale, CA. | Hospital/Nursing Management | Founder | |
| Soochow University | College/University | Undergraduate Degree | |
| COXON PRECISE INDUSTRIAL CO., LTD | Containers/Packaging | Director/Board Member |
Statistiques
Internationale
| Taïwan | 5 |
| Etats-Unis | 3 |
| Chine | 2 |
Sectorielle
| Consumer Services | 3 |
| Distribution Services | 2 |
| Retail Trade | 2 |
| Health Technology | 2 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 20 |
| Chairman | 3 |
| Undergraduate Degree | 3 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Relations les plus connectées
| Insiders | |
|---|---|
| Chih Ping Liu | 12 |
| Li Hsien Chen | 8 |
| Shu Chuan Chang | 6 |
| Kieran Fowler Chapman | 1 |
- Bourse
- Insiders
- Ho Hsiang Yeh
- Connexions Sociétés
